Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)

Clinical trial NCT01172652 · COMPLETED

Trial details

NCT number: NCT01172652
Sponsor: VA Palo Alto Health Care System
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bipolar Disorder Panic Disorder Generalized Anxiety Disorder

Start date: 2010-04-01
Primary completion: 2011-10-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.